{"title":"发现双查尔酮和双嘧啶作为潜在的脲酶抑制剂:从合成到计算的见解。","authors":"Nafeesa Naeem, Sumera Zaib, Ehsan Ullah Mughal, Gehan Ahmed Othman, Amina Sadiq, Nehal Rana","doi":"10.1080/17568919.2025.2485870","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>This study focuses on the design and evaluation of <i>bis</i>-chalcones and <i>bis</i>-pyrimidines as potential urease inhibitors.</p><p><strong>Materials and methods: </strong>A series of <i>bis</i>-chalcone and <i>bis</i>-pyrimidine derivatives were synthesized and assessed for their <i>in vitro</i> urease inhibitory activity. Kinetic studies were conducted using Lineweaver-Burk plots to determine the inhibition mechanism of the most potent compound. Molecular docking was employed to investigate the binding interactions with the urease active site, followed by MD simulations to validate complex stability. Computational ADMET analysis was performed to assess the drug-like properties of the most active inhibitor.</p><p><strong>Results: </strong>Several synthesized compounds exhibited potent urease inhibitory activity, significantly surpassing the standard inhibitor thiourea. The most active compound, 8P, displayed noncompetitive inhibition, as confirmed by kinetic studies. SAR analysis revealed that electron-withdrawing substituents enhanced inhibitory potency. Molecular docking studies demonstrated favorable interactions between inhibitors and key urease residues, while MD simulations confirmed complex stability. ADMET analysis supported the drug-like potential of 8P.</p><p><strong>Conclusions: </strong>This study provides valuable insights into the development of target compounds as promising urease inhibitors. These findings suggest their potential therapeutic applications for urease-related disorders.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":" ","pages":"1-13"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Discovery of <i>bis</i>-chalcones and <i>bis</i>-pyrimidines as potential urease inhibitors: from synthesis to computational insights.\",\"authors\":\"Nafeesa Naeem, Sumera Zaib, Ehsan Ullah Mughal, Gehan Ahmed Othman, Amina Sadiq, Nehal Rana\",\"doi\":\"10.1080/17568919.2025.2485870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>This study focuses on the design and evaluation of <i>bis</i>-chalcones and <i>bis</i>-pyrimidines as potential urease inhibitors.</p><p><strong>Materials and methods: </strong>A series of <i>bis</i>-chalcone and <i>bis</i>-pyrimidine derivatives were synthesized and assessed for their <i>in vitro</i> urease inhibitory activity. Kinetic studies were conducted using Lineweaver-Burk plots to determine the inhibition mechanism of the most potent compound. Molecular docking was employed to investigate the binding interactions with the urease active site, followed by MD simulations to validate complex stability. Computational ADMET analysis was performed to assess the drug-like properties of the most active inhibitor.</p><p><strong>Results: </strong>Several synthesized compounds exhibited potent urease inhibitory activity, significantly surpassing the standard inhibitor thiourea. The most active compound, 8P, displayed noncompetitive inhibition, as confirmed by kinetic studies. SAR analysis revealed that electron-withdrawing substituents enhanced inhibitory potency. Molecular docking studies demonstrated favorable interactions between inhibitors and key urease residues, while MD simulations confirmed complex stability. ADMET analysis supported the drug-like potential of 8P.</p><p><strong>Conclusions: </strong>This study provides valuable insights into the development of target compounds as promising urease inhibitors. These findings suggest their potential therapeutic applications for urease-related disorders.</p>\",\"PeriodicalId\":12475,\"journal\":{\"name\":\"Future medicinal chemistry\",\"volume\":\" \",\"pages\":\"1-13\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future medicinal chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17568919.2025.2485870\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17568919.2025.2485870","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Discovery of bis-chalcones and bis-pyrimidines as potential urease inhibitors: from synthesis to computational insights.
Aims: This study focuses on the design and evaluation of bis-chalcones and bis-pyrimidines as potential urease inhibitors.
Materials and methods: A series of bis-chalcone and bis-pyrimidine derivatives were synthesized and assessed for their in vitro urease inhibitory activity. Kinetic studies were conducted using Lineweaver-Burk plots to determine the inhibition mechanism of the most potent compound. Molecular docking was employed to investigate the binding interactions with the urease active site, followed by MD simulations to validate complex stability. Computational ADMET analysis was performed to assess the drug-like properties of the most active inhibitor.
Results: Several synthesized compounds exhibited potent urease inhibitory activity, significantly surpassing the standard inhibitor thiourea. The most active compound, 8P, displayed noncompetitive inhibition, as confirmed by kinetic studies. SAR analysis revealed that electron-withdrawing substituents enhanced inhibitory potency. Molecular docking studies demonstrated favorable interactions between inhibitors and key urease residues, while MD simulations confirmed complex stability. ADMET analysis supported the drug-like potential of 8P.
Conclusions: This study provides valuable insights into the development of target compounds as promising urease inhibitors. These findings suggest their potential therapeutic applications for urease-related disorders.
期刊介绍:
Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.